The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group (Q73194067)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

T J Schnitzer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Truitt

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Fleischmann

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Dalgin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Q Zeng

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Bolognese

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B Seidenberg

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E W Ehrich

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1688-1702

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory drugs and their mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled studies in rheumatoid arthritis: ethical issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980048-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(99)80048-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566565%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73194067&oldid=1933730602"